Bajaj Healthcare Limited

Bajaj Healthcare Limited (BAJAJHCARE) is a micro-cap Healthcare company valued at ₹1,144 crore operating in Pharmaceuticals on the NSE and BSE.

Recent price move

Bajaj Healthcare Limited last traded at ₹330.85, down 2.35% on the day.

Recent developments

On 2026-09-11, the company announced a dividend of ₹1.50 per share, ex-date. Promoter holding increased by 0.30 percentage points to 58.59% in the latest quarter. Foreign institutional holding rose 0.21 percentage points to 2.19%, while domestic institutional holding fell 0.99 percentage points to 1.92%.

Financial performance

The company's annual revenue rose 12.5% to ₹611 crore, but net profit fell 60.6% to ₹16 crore. In the latest quarter, revenue increased 11.2% year-over-year to ₹166 crore, while net profit rose 14.2% to ₹14 crore, showing some improvement in profitability.

Valuation multiples

The stock trades at 66.4 times earnings, a premium to the Healthcare median of 32.0, 2.10 times book value. It yields 0.5%.

Things to watch

Net profit margin narrowed 4.8 percentage points to 2.6%, and return on equity fell to 3.0%. The stock is 36.2% below its 52-week high, and profit has declined significantly over the past five years, with a 28.3% annualized drop. The company also reported a net profit loss in the quarter ending March 2026.

Where it stands

Bajaj Healthcare Limited's latest quarter showed a rise in revenue and net profit compared to the same period last year, but annual net profit has declined sharply. The stock is trading below its 52-week high, and the company's profitability has deteriorated over the past five years. The most significant movement was in net profit, which rose 14.2% in the latest quarter.

Summarised by DocStoX's model on 2026-10-04 from company filings, exchange data and news. This is a factual summary, not a rating or a recommendation. Informational only, not investment advice. Consult a SEBI-registered adviser before investing.